Literature DB >> 33666853

Feasibility of robotic right colectomy with complete mesocolic excision and intracorporeal anastomosis: short-term outcomes of 161 consecutive patients.

Paolo Pietro Bianchi1, Adelona Salaj2, Giuseppe Giuliani3, Luca Ferraro4, Giampaolo Formisano3.   

Abstract

Technical and oncological aspects are still debated when dealing with minimally-invasive right colectomy. Main controversial issues still remain about whether the anastomosis should be performed intra- or extracorporeally and if a complete mesocolic excision (CME) should be carried out. We report the feasibility of robotic right colectomy with CME and intracorporeal anastomosis (IA) for right sided colon cancer. Data from patients who underwent robotic right colectomy with IA and CME from January 2015 to April 2020 were prospectively collected and retrospectively analyzed. Intraoperative outcomes and complications (minor I-II and major III-IV according to Clavien-Dindo classification), conversion rate, 30-day postoperative outcomes and pathological outcomes were the variables assessed. A total of 161 patients undergoing robotic right colectomy for cancer met the inclusion criteria. Mean operative time was 185 min, no intraoperative complications were observed, and the conversion rate was 3.7% (6 patients requiring elective conversions). Overall, mean postoperative stay was 4.9 days and the overall 30-day complication rate was 16.1%. 20 patients (12.4%) had minor complications, while major postoperative complications occurred in six patients (3.7%). Anastomotic leak was recorded in one patient (0.6%) and the 30-day re-admission rate was 0.6%. Mean number of harvested lymph nodes was 21.9. Patients requiring conversion experienced two minor complications, with a mean length of stay of 7 days. Robotic right colectomy with CME and IA is feasible and it is associated with good intraoperative and short-term postoperative clinical outcomes.

Entities:  

Keywords:  Complete mesocolic excision; Intracorporeal anastomosis; Robotic colorectal surgery; Robotic right colectomy; Robotic surgery

Year:  2021        PMID: 33666853     DOI: 10.1007/s13304-021-01001-x

Source DB:  PubMed          Journal:  Updates Surg        ISSN: 2038-131X


  30 in total

1.  Growth in robotic-assisted procedures is from conversion of laparoscopic procedures and not from open surgeons' conversion: a study of trends and costs.

Authors:  Priscila R Armijo; Spyridon Pagkratis; Eugene Boilesen; Tiffany Tanner; Dmitry Oleynikov
Journal:  Surg Endosc       Date:  2017-10-24       Impact factor: 4.584

2.  Elective surgery for diverticular disease in U.S. veterans: A VASQIP study of national trends and outcomes from 2004 to 2018.

Authors:  Michael A Napolitano; Andrew D Sparks; J Alex Randall; Fred J Brody; James E Duncan
Journal:  Am J Surg       Date:  2020-09-08       Impact factor: 2.565

3.  Minimally invasive colectomy is associated with reduced risk of anastomotic leak and other major perioperative complications and reduced hospital resource utilization as compared with open surgery: a retrospective population-based study of comparative effectiveness and trends of surgical approach.

Authors:  David Wei; Stephen Johnston; Laura Goldstein; Deborah Nagle
Journal:  Surg Endosc       Date:  2019-05-14       Impact factor: 4.584

4.  Is laparoscopic right colectomy more effective than open resection? A meta-analysis of randomized and nonrandomized studies.

Authors:  F Rondelli; S Trastulli; N Avenia; G Schillaci; R Cirocchi; N Gullà; E Mariani; G Bistoni; G Noya
Journal:  Colorectal Dis       Date:  2012-08       Impact factor: 3.788

5.  Intracorporeal versus extracorporeal anastomosis in laparoscopic right hemicolectomy: results from the CLIMHET study group.

Authors:  N Bou Saleh; T Voron; N De'Angelis; I Franco; F Canoui-Poitrine; D Mutter; F Brunetti; J Gagnière; R Memeo; D Pezet; B Monange; B Pereira; B Le Roy
Journal:  Tech Coloproctol       Date:  2020-04-14       Impact factor: 3.781

6.  Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial.

Authors:  Mark Buunen; Ruben Veldkamp; Wim C J Hop; Esther Kuhry; Johannes Jeekel; Eva Haglind; Lars Påhlman; Miguel A Cuesta; Simon Msika; Mario Morino; Antonio Lacy; Hendrik J Bonjer
Journal:  Lancet Oncol       Date:  2008-12-13       Impact factor: 41.316

7.  Comparison of Open, Laparoscopic, and Robotic Colectomies Using a Large National Database: Outcomes and Trends Related to Surgery Center Volume.

Authors:  Heather L Yeo; Abby J Isaacs; Jonathan S Abelson; Jeffrey W Milsom; Art Sedrakyan
Journal:  Dis Colon Rectum       Date:  2016-06       Impact factor: 4.585

8.  Intracorporeal or Extracorporeal Ileocolic Anastomosis After Laparoscopic Right Colectomy: A Double-blinded Randomized Controlled Trial.

Authors:  Marco E Allaix; Maurizio Degiuli; Marco A Bonino; Alberto Arezzo; Massimiliano Mistrangelo; Roberto Passera; Mario Morino
Journal:  Ann Surg       Date:  2019-11       Impact factor: 12.969

9.  Intracorporeal Anastomoses in Minimally Invasive Right Colectomies Are Associated With Fewer Incisional Hernias and Shorter Length of Stay.

Authors:  Maria Widmar; Piyush Aggarwal; Metin Keskin; Paul D Strombom; Sujata Patil; J Joshua Smith; Garrett M Nash; Julio Garcia-Aguilar
Journal:  Dis Colon Rectum       Date:  2020-05       Impact factor: 4.412

10.  Long-term follow-up of the Medical Research Council CLASICC trial of conventional versus laparoscopically assisted resection in colorectal cancer.

Authors:  B L Green; H C Marshall; F Collinson; P Quirke; P Guillou; D G Jayne; J M Brown
Journal:  Br J Surg       Date:  2012-11-06       Impact factor: 6.939

View more
  1 in total

Review 1.  Robot-assisted versus laparoscopic short- and long-term outcomes in complete mesocolic excision for right-sided colonic cancer: a systematic review and meta-analysis.

Authors:  Pedja Cuk; Mohamad Jawhara; Issam Al-Najami; Per Helligsø; Andreas Kristian Pedersen; Mark Bremholm Ellebæk
Journal:  Tech Coloproctol       Date:  2022-08-24       Impact factor: 3.699

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.